文献速递关节外科创伤骨科

他汀类药物使用与全髋关节置换术后静脉血栓栓塞事件减少相关:一项匹配回顾性队列研究

Statin Use Is Associated With Decreased Venous Thromboembolism Events Following Total Hip Arthroplasty: A Matched Retrospective Cohort Study.
PubMed 文献 · J Arthroplasty · 2025-01-25

该匹配回顾性队列研究纳入2012年1月1日至2023年6月1日在大型城市学术中心接受初次全髋关节置换术且术前使用他汀至少4周的1154例患者,采用倾向性匹配控制人口学与部分合并症。术前他汀使用与90天静脉血栓栓塞事件率显著降低相关(他汀组0.43% vs 无他汀组1.13%,P=0.047),90天肺栓塞、深静脉血栓、急诊就诊、再入院或再手术率无显著差异,两组均无死亡。他汀强度亚组分析显示高强度、中等强度与低强度组间所有结局无显著差异。

要点

  • 术前他汀使用与全髋关节置换术后90天静脉血栓栓塞事件率显著降低相关(0.43% vs 1.13%,P=0.047)。
  • 90天肺栓塞、深静脉血栓、急诊就诊、再入院或再手术率在他汀组与无他汀组间无显著差异。
  • 他汀强度亚组分析显示高强度、中等强度与低强度组间所有测量结局无显著差异。

核心结论

  • 术前他汀使用与全髋关节置换术后90天静脉血栓栓塞事件率显著降低相关。
  • 作者认为需要进一步研究他汀对全髋关节置换术后静脉血栓栓塞的影响。

研究设计与样本

  • 匹配回顾性队列研究,纳入2012年1月1日至2023年6月1日在大型城市学术中心接受初次全髋关节置换术且术前使用他汀至少4周的1154例患者。
  • 采用倾向性匹配控制人口学与部分合并症。

主要发现

  • 术前他汀使用与90天静脉血栓栓塞事件率显著降低相关(他汀组0.43% vs 无他汀组1.13%,P=0.047)。
  • 90天肺栓塞、深静脉血栓、急诊就诊、再入院或再手术率在他汀组与无他汀组间无显著差异。
  • 两组在髋关节置换术后90天内均无死亡。
  • 他汀强度亚组分析显示高强度、中等强度与低强度组间所有测量结局无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite advances in surgical techniques and postoperative prophylactic protocols, venous thromboembolism (VTE) events remain an important source of morbidity following total hip arthroplasty (THA). Prior research in cardiology and other surgical fields has suggested that statin medications may have a protective effect against VTE. Our study aimed to: (1) assess if preoperative statin use was associated with decreased rates of VTE following THA; and (2) conduct a subgroup analysis of statin intensity and VTE events. METHODS: A total of 1,154 patients who had preoperative statin use for at least four weeks before surgery and who underwent primary THA at a large, urban academic center between January 1, 2012, and June 1, 2023, were identified. The 90-day postoperative VTE events, deep vein thrombosis, pulmonary embolism, emergency department visits, reoperations, and readmission rates were collected from institutional coding software. Mortality rate in the 90-day postoperative period was also measured. Propensity matching was used to control for demographics and selected comorbidities. RESULTS: Preoperative statin use was associated with significantly lower rates of 90-day VTE events (Statin: 0.43% versus No-Statin: 1.13%, P = 0.047). There were no significant differences in 90-day PE, deep vein thrombosis, emergency department visit, readmission, or reoperation rates. There were no deaths within 90 days of THA in either group. Subgroup analysis of statin intensity revealed no significant differences in any outcomes measured between high-intensity, medium-intensity, and low-intensity statin groups. CONCLUSIONS: Preoperative statin use is associated with significantly lower rates of VTE events in the 90-day postoperative period following THA. Further research into the effect of statins on post-THA VTE is warranted.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Lan R, Vallurupalli N, Aggarwal VK, et al. Statin Use Is Associated With Decreased Venous Thromboembolism Events Following Total Hip Arthroplasty: A Matched Retrospective Cohort Study. J Arthroplasty. 2025. PMID: 39870331. doi:10.1016/j.arth.2025.01.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。